These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 24550101)

  • 1. Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.
    Babu A; Templeton AK; Munshi A; Ramesh R
    AAPS PharmSciTech; 2014 Jun; 15(3):709-21. PubMed ID: 24550101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy.
    Ganta S; Talekar M; Singh A; Coleman TP; Amiji MM
    AAPS PharmSciTech; 2014 Jun; 15(3):694-708. PubMed ID: 24510526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery systems using polymer nanoassemblies for cancer treatment.
    Bae Y
    Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
    [No Abstract]   [Full Text] [Related]  

  • 5. Polymeric nano-micelles: versatile platform for targeted delivery in cancer.
    Mohamed S; Parayath NN; Taurin S; Greish K
    Ther Deliv; 2014 Oct; 5(10):1101-21. PubMed ID: 25418269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review.
    Indoria S; Singh V; Hsieh MF
    Int J Pharm; 2020 May; 582():119314. PubMed ID: 32283197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.
    Heneweer C; Gendy SE; Peñate-Medina O
    Ther Deliv; 2012 May; 3(5):645-56. PubMed ID: 22834408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting liposomes toward novel pediatric anticancer therapeutics.
    Federman N; Denny CT
    Pediatr Res; 2010 May; 67(5):514-9. PubMed ID: 20118828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size matters: gold nanoparticles in targeted cancer drug delivery.
    Dreaden EC; Austin LA; Mackey MA; El-Sayed MA
    Ther Deliv; 2012 Apr; 3(4):457-78. PubMed ID: 22834077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors.
    Stylianopoulos T
    Ther Deliv; 2013 Apr; 4(4):421-3. PubMed ID: 23557281
    [No Abstract]   [Full Text] [Related]  

  • 13. Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects.
    Wang Y; Wei X; Zhang C; Zhang F; Liang W
    Ther Deliv; 2010 Aug; 1(2):273-87. PubMed ID: 22816133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine: An effective tool in cancer therapy.
    Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
    Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions.
    Garg NK; Tandel N; Jadon RS; Tyagi RK; Katare OP
    Drug Discov Today; 2018 Sep; 23(9):1610-1621. PubMed ID: 29857164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
    Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
    Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoengineered drug delivery systems for enhancing antibiotic therapy.
    Kalhapure RS; Suleman N; Mocktar C; Seedat N; Govender T
    J Pharm Sci; 2015 Mar; 104(3):872-905. PubMed ID: 25546108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers.
    Caldorera-Moore ME; Liechty WB; Peppas NA
    Acc Chem Res; 2011 Oct; 44(10):1061-70. PubMed ID: 21932809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain.
    Leyva-Gómez G; Cortés H; Magaña JJ; Leyva-García N; Quintanar-Guerrero D; Florán B
    Drug Discov Today; 2015 Jul; 20(7):824-37. PubMed ID: 25701281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.